Frontometaphyseal dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1826OMIM:305620Q78.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Frontometaphyseal dysplasia (FMD) is a rare skeletal disorder belonging to the group of otopalatodigital spectrum disorders. It is characterized by prominent supraorbital ridges (frontal bossing), which give the face a distinctive appearance, combined with abnormal modeling (metaphyseal dysplasia) of the long bones. The condition affects multiple body systems including the skeletal, craniofacial, auditory, and respiratory systems. Key craniofacial features include a prominent brow ridge, wide nasal bridge, small mandible (micrognathia), and dental anomalies. Skeletal manifestations include bowing of the long bones, joint contractures (particularly of the fingers and toes), scoliosis, and metaphyseal flaring. Conductive hearing loss is common due to abnormalities of the ossicles in the middle ear. Some patients may develop subglottic stenosis (narrowing of the airway below the vocal cords), which can be a serious and potentially life-threatening complication. Frontometaphyseal dysplasia is most commonly caused by gain-of-function mutations in the FLNA gene (filamin A), located on the X chromosome. A second form (FMD type 2) has been associated with mutations in the MAP3K7 gene, inherited in an autosomal dominant pattern. Males with FLNA-related FMD tend to be more severely affected than females, who may show milder or variable features. The condition is typically recognized in childhood based on the characteristic facial features and skeletal abnormalities, with radiographic findings confirming the diagnosis. There is currently no cure for frontometaphyseal dysplasia. Treatment is supportive and multidisciplinary, focusing on managing specific symptoms. This may include hearing aids for conductive hearing loss, orthopedic interventions for skeletal deformities and joint contractures, dental care, and surgical management of airway obstruction when subglottic stenosis is present. Regular monitoring by specialists in genetics, orthopedics, otolaryngology, and audiology is recommended to address complications as they arise.

Clinical phenotype terms— hover any for plain English:

Joint contracture of the handHP:0009473Short phalanx of fingerHP:0009803Long fingersHP:0100807Short diaphysesHP:0000941Interphalangeal joint contracture of fingerHP:0001220
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Frontometaphyseal dysplasia.

View clinical trials →

No actively recruiting trials found for Frontometaphyseal dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Frontometaphyseal dysplasia community →

No specialists are currently listed for Frontometaphyseal dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Frontometaphyseal dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Frontometaphyseal dysplasiaForum →

No community posts yet. Be the first to share your experience with Frontometaphyseal dysplasia.

Start the conversation →

Latest news about Frontometaphyseal dysplasia

No recent news articles for Frontometaphyseal dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Frontometaphyseal dysplasia

What is Frontometaphyseal dysplasia?

Frontometaphyseal dysplasia (FMD) is a rare skeletal disorder belonging to the group of otopalatodigital spectrum disorders. It is characterized by prominent supraorbital ridges (frontal bossing), which give the face a distinctive appearance, combined with abnormal modeling (metaphyseal dysplasia) of the long bones. The condition affects multiple body systems including the skeletal, craniofacial, auditory, and respiratory systems. Key craniofacial features include a prominent brow ridge, wide nasal bridge, small mandible (micrognathia), and dental anomalies. Skeletal manifestations include bow

At what age does Frontometaphyseal dysplasia typically begin?

Typical onset of Frontometaphyseal dysplasia is childhood. Age of onset can vary across affected individuals.